Intuitive Surgical (NASDAQ:ISRG) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Intuitive Surgical (NASDAQ:ISRG) from a hold rating to a buy rating in a research note released on Saturday morning.

ISRG has been the topic of several other reports. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research note on Friday, August 22nd. Truist Financial set a $620.00 price objective on Intuitive Surgical and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Argus upped their target price on shares of Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Evercore ISI raised their target price on shares of Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Finally, UBS Group set a $600.00 price target on shares of Intuitive Surgical and gave the stock a “neutral” rating in a report on Thursday, October 23rd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $608.92.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $568.48 on Friday. The firm has a market cap of $203.79 billion, a price-to-earnings ratio of 75.20, a PEG ratio of 4.94 and a beta of 1.62. The firm has a 50 day simple moving average of $494.78 and a 200-day simple moving average of $504.11. Intuitive Surgical has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion for the quarter, compared to analyst estimates of $2.41 billion. During the same period in the prior year, the business earned $1.84 EPS. The firm’s quarterly revenue was up 22.9% on a year-over-year basis. Equities analysts predict that Intuitive Surgical will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction dated Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the sale, the executive vice president owned 3,056 shares in the company, valued at approximately $1,772,480. The trade was a 81.80% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 29,360 shares of the company’s stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 116,164 shares of company stock valued at $61,916,172. Corporate insiders own 0.70% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors have recently modified their holdings of ISRG. Brighton Jones LLC increased its stake in Intuitive Surgical by 24.9% in the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after purchasing an additional 731 shares during the period. AE Wealth Management LLC increased its position in Intuitive Surgical by 32.6% in the 1st quarter. AE Wealth Management LLC now owns 8,407 shares of the medical equipment provider’s stock valued at $4,164,000 after acquiring an additional 2,066 shares during the period. Avantax Advisory Services Inc. lifted its position in Intuitive Surgical by 2.1% during the 1st quarter. Avantax Advisory Services Inc. now owns 23,334 shares of the medical equipment provider’s stock worth $11,556,000 after acquiring an additional 485 shares during the period. Cetera Investment Advisers grew its stake in shares of Intuitive Surgical by 15.0% in the 1st quarter. Cetera Investment Advisers now owns 77,302 shares of the medical equipment provider’s stock valued at $38,285,000 after purchasing an additional 10,100 shares during the last quarter. Finally, Equitable Trust Co. increased its holdings in shares of Intuitive Surgical by 8.0% in the first quarter. Equitable Trust Co. now owns 3,154 shares of the medical equipment provider’s stock valued at $1,562,000 after purchasing an additional 234 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.